Netherlands· NL-c6f0301d7739
Lyvdelzi 10 mg harde capsules
A seladelpar product containing seladelpar lysine 2-water, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Seladelpar is registered in 11 of 19 countries.
Countries holding a registration under ATC A05AX07 (seladelpar), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Seladelpar · ATC A05AX07
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SELADELPAR LYSINE 2-WATER
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Netherlands (NL)
- ATC code
- A05AX07
- ATC class
- Seladelpar
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/24/1898
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Seladelpar in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandLyvdelzi 10 mg, HartkapselnGilead Sciences Switzerland Sàrl
- SpainLYVDELZI 10 MG CAPSULAS DURASGilead Sciences Ireland Unlimited Company
- United KingdomLivdelzi 10mg capsulesGilead Sciences Ltd
- NorwayLyvdelziGilead Sciences Ireland UC
- PolandLyvdelziGilead Sciences Ireland UC
- SwedenLyvdelzi 10 mg Kapsel, hårdGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lyvdelzi
- Liechtenstein · Lyvdelzi
- Norway · Lyvdelzi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5cf2bba-9b8d-4363-be69-cd2cdc9c0a07 GET /v1/drugs/b5cf2bba-9b8d-4363-be69-cd2cdc9c0a07?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lyvdelzi-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Seladelpar",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133060",
"excipients": [
"BUTYLHYDROXYTOLUEEN (E 321)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GELATINE (E 441)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"IJZEROXIDE ZWART (E 172)",
"INDIGOKARMIJN (E 132)",
"KALIUMHYDROXIDE (E 525)",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)",
"POVIDON (E 1201)",
"PROPYLEENGLYCOL (E 1520)",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK (E 904)",
"SCHELLAK (E 904)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)",
"WITTE INKT",
"ZWARTE INKT"
],
"substances": [
"SELADELPAR LYSINE 2-WATER"
],
"leaflet_url": null,
"authorised_at": "2025/02/20",
"procedure_number": "EMEA/H/C/004692",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1898",
"additional_monitoring": "Y"
}See everything about seladelpar.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.